Lung cancer prognosis before and after recurrence in a population-based setting.-论文-万方医学网

第一作者： Dario,Consonni

第一单位： Epidemiology Unit, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy (DC, PAB, ACP); Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA (MP); Genetic Epidemiology Branch (MP, MRo, AG, LG, NEC, MAT, MTL) and Biostatistics Branch (MHG, JL, SW), Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD; Department of Clinical Sciences and Community Health, Universita' degli Studi di Milano, Milan, Italy (MRu, PAB, ACP).

作者： Dario,Consonni ^[1] ; Mariaelena,Pierobon ^[1] ; Mitchell H,Gail ^[2] ; Maurizia,Rubagotti ^[1] ; Melissa,Rotunno ^[1] ; Alisa,Goldstein ^[1] ; Lynn,Goldin ^[1] ; Jay,Lubin ^[1] ; Sholom,Wacholder ^[1] ; Neil E,Caporaso ^[1] ; Pier Alberto,Bertazzi ^[1] ; Margaret A,Tucker ^[1] ; Angela C,Pesatori ^[1] ; Maria Teresa,Landi ^[2]

作者单位： Epidemiology Unit, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy (DC, PAB, ACP); Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA (MP); Genetic Epidemiology Branch (MP, MRo, AG, LG, NEC, MAT, MTL) and Biostatistics Branch (MHG, JL, SW), Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD; Department of Clinical Sciences and Community Health, Universita' degli Studi di Milano, Milan, Italy (MRu, PAB, ACP). ^[1] Epidemiology Unit, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy (DC, PAB, ACP); Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA (MP); Genetic Epidemiology Branch (MP, MRo, AG, LG, NEC, MAT, MTL) and Biostatistics Branch (MHG, JL, SW), Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD; Department of Clinical Sciences and Community Health, Universita' degli Studi di Milano, Milan, Italy (MRu, PAB, ACP). landim@mail.nih.gov gailm@mail.nih.gov. ^[2]

主题词腺癌(Adenocarcinoma);成年人(Adult);老年人(Aged);脑肿瘤(Brain Neoplasms);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);癌, 鳞状细胞(Carcinoma, Squamous Cell);化学疗法, 辅助(Chemotherapy, Adjuvant);女(雌)性(Female);人类(Humans);意大利(Italy);Kaplan-Meiers评估(Kaplan-Meier Estimate);肺肿瘤(Lung Neoplasms);男(雄)性(Male);病案连锁(Medical Record Linkage);中年人(Middle Aged);肿瘤复发, 局部(Neoplasm Recurrence, Local);肿瘤分期(Neoplasm Staging);肺切除术(Pneumonectomy);预后(Prognosis);放射疗法, 辅助(Radiotherapy, Adjuvant);危险性评估(Risk Assessment);危险因素(Risk Factors)

DOI 10.1093/jnci/djv059

PMID 25802059

发布时间 2022-03-31

检索历史清除

Lung cancer prognosis before and after recurrence in a population-based setting.

Journal of the National Cancer Institute

相似文献

Journal of the National Cancer Institute

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Lung cancer prognosis before and after recurrence in a population-based setting.

Journal of the National Cancer Institute

相似文献

Journal of the National Cancer Institute

相关期刊

检索历史清除